European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 135, Issue 1 , Pages 3-7 , November 2007

Pregnancy rates after conservative treatment for borderline ovarian tumours: A systematic review

  • Alexander Swanton

      Affiliations

    • Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom
    • ,
  • Clare R. Bankhead

      Affiliations

    • Cancer Research UK, Primary Care Education Research Group, University of Oxford, United Kingdom
    • ,
  • Sean Kehoe

      Affiliations

    • Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 1865 857942; fax: +44 1865 221001.

Received 5 February 2007 ,Revised 14 May 2007 ,Accepted 24 May 2007.

References 

  1. Barakat RR. Borderline tumors of the ovary. Obstet Gynecol Clin North Am. 1994;21:93–105
  2. Taylor HC. Malignant and semi-malignant tumours of the ovary. Surg Gynecol Obstet. 1929;48:204–230
  3. FIGO . International Federation of Gynecology and Obstetrics Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand. 1971;50:1–7
  4. Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer. 1973;31:1031–1045
  5. Scully RE. World Health Organization classification and nomenclature of ovarian cancer. Natl Cancer Inst Monogr. 1975;42:5–7
  6. Seracchioli R, Venturoli S, Colombo FM, Govoni F, Missiroli S, Bagnoli A. Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors. Fertil Steril. 2001;76:999–1004
  7. Barnhill DR, Kurman RJ, Brady MF, et al. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol. 1995;13:2752–2756
  8. Kurman RJ, Trimble CL. The behavior of serous tumors of low malignant potential: are they ever malignant?. Int J Gynecol Pathol. 1993;12(2):120–127
  9. Gershenson DM, Silva EG. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer. 1990;65:578–585
  10. Nikrui N. Survey of clinical behavior of patients with borderline epithelial tumors of the ovary. Gynecol Oncol. 1981;12:107–119
  11. Casey AC, Bell DA, Lage JM, Fuller AF, Nikrui N, Rice LW. Epithelial ovarian tumors of borderline malignancy: long-term follow-up. Gynecol Oncol. 1993;50:316–322
  12. Leake JF, Currie JL, Rosenshein NB, Woodruff JD. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol. 1992;47:150–158
  13. Massad LS, Hunter VJ, Szpak CA, Clarke Pearson DL, Creasman WT. Epithelial ovarian tumors of low malignant potential. Obstet Gynecol. 1991;78:1027–1032
  14. Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors): a long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer. 1996;78:278–286
  15. Bjorge T, Engeland A, Hansen S, Trope CG. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954–1993. Int J Cancer. 1997;71:780–786
  16. FIGO . International Federation of Gynecology and Obstetrics Annual report and results of treatment in gynecologic cancer. Int J Gynaecol Obstet. 1989;28:189–190
  17. Creasman WT, Park R, Norris H, Disaia PJ, Morrow CP, Hreshchyshyn MM. Stage I borderline ovarian tumors. Obstet Gynecol. 1982;59:93–96
  18. Lim Tan SK, Cajigas HE, Scully RE. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases. Obstet Gynecol. 1988;72:775–781
  19. Chan JK, Lin YG, Loizzi V, Ghobriel M, DiSaia PJ, Berman ML. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome. J Reprod Med. 2003;48:756–760
  20. Tazelaar HD, Bostwick DG, Ballon SC, Hendrickson MR, Kempson RL. Conservative treatment of borderline ovarian tumors. Obstet Gynecol. 1985;66:417–422
  21. Rao GG, Skinner EN, Gehrig PA, Duska LR, Miller DS, Schorge JO. Fertility-sparing surgery for ovarian low malignant potential tumors. Gynecol Oncol. 2005;98:263–266
  22. Hull MG, Glazener CM, Kelly NJ, et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed). 1985;291:1693–1697
  23. Demeter A, Csapo Z, Szantho A, Balega J, Sipos N, Papp Z. A retrospective study of 27 ovarian tumors of low malignant potential. Eur J Gynaecol Oncol. 2002;23:415–418
  24. Makarewicz H, Olszewski J, Konefka T, Emerich J. Pregnancy, labor and puerperium in patients after surgery for ovarian tumors of borderline malignancy. Ginekol Pol. 1998;69:1089–1092
  25. Fauvet R, Poncelet C, Boccara J, Descamps P, Fondrinier E, Darai E. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril. 2005;83:284–290
  26. Romagnolo C, Gadducci A, Sartori E, Zola P, Maggino T. Management of borderline ovarian tumors: results of an Italian multicenter study. Gynecol Oncol. 2006;101:255–260
  27. Boran N, Cil AP, Tulunay G, et al. Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol. 2005;97:845–851
  28. Olszewska H, Lapinska Szumczyk S, Kobierski J, Stukan M, Emerich J. Fertility of women after conservative operation for borderline ovarian tumors. Ginekol Pol. 2004;75:533–537
  29. Donnez J, Munschke A, Berliere M, et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril. 2003;79:1216–1221
  30. Camatte S, Rouzier R, Boccara Dekeyser J, et al. Prognosis and fertility results after conservative management of ovarian borderline tumors: review of 68 cases. Gynecol Obstet Fertil. 2002;30:583–591
  31. Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol. 2001;19:2658–2664
  32. Morris RT, Gershenson DM, Silva EG, Follen M, Morris M, Wharton JT. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol. 2000;95:541–547
  33. Papadimitriou DS, Martin Hirsch P, Kitchener HC, Lolis DE, Dalkalitsis N, Paraskevaidis E. Recurrent borderline ovarian tumours after conservative management in women wishing to retain their fertility. Eur J Gynaecol Oncol. 1999;20:94–97
  34. Gotlieb WH, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben Baruch G. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer. 1998;82:141–146
  35. Armas A, Hernandez Cortes G, Rodriguez R, Calero F. Epithelial borderline ovary tumors: retrospective study of 53 cases. Prog Obstet Gynecol. 1997;40:637–644
  36. Ji H, Yliskoski M, Anttila M, Syrjanen K, Saarikoski S. Management of stage-I borderline ovarian tumors. Int J Gynaecol Obstet. 1996;54:37–44

PII: S0301-2115(07)00233-3

doi: 10.1016/j.ejogrb.2007.05.011

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 135, Issue 1 , Pages 3-7 , November 2007

Article Tools